In vivo cancer vaccination: Which dendritic cells to target and how?

Title
In vivo cancer vaccination: Which dendritic cells to target and how?
Authors
Keywords
Tumor immunotherapy, Dendritic cells, Cancer vaccination, Toll-like receptor, Toll-like receptor agonists, Anti-tumor responses
Journal
CANCER TREATMENT REVIEWS
Volume 71, Issue -, Pages 88-101
Publisher
Elsevier BV
Online
2018-10-26
DOI
10.1016/j.ctrv.2018.10.012

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started